The Cheung lab receives a 3-year grant from the Kuni Foundation to develop a therapeutic antibody to prevent necrosis, metastatic dissemination, and therapy resistance. Our goal for this project is to develop a therapeutic antibody that will be advanced to early phase clinical trial. We are grateful to the Kuni Foundation for their generous support!